BIOFORM MEDICAL INC (BFRM) [Rocket]

In millions, except per share items	Jun-30-09	Jun-30-08	Jun-30-07	Jun-30-06	Jun-30-05
	10-K	10-K	10-K	10-K	S-1/A
Revenues:
Domestic	53.7	54.4	39.2	19.5
International	12.9	13.1	8.2	3.2
Total revenues	66.5	67.5	47.4	22.7	16.2
Revenue growth [+]	-1.4%	42.3%	109.3%	39.6%
Domestic	-1.4%	38.7%	101.3%
International	-1.7%	59.7%	158.6%
Cost of goods sold	13.0	11.4	8.8	4.3	2.9
Gross profit	53.5	56.1	38.6	18.4	13.3
Gross margin	80.4%	83.1%	81.5%	81.2%	82.0%
Selling, general and administrative [+]	64.8	66.8	45.2	25.7	18.7
Sales and marketing	54.6	56.9	38.2	20.7	11.7
General and administrative	10.2	9.9	7.0	5.0	7.0
Research and development	9.6	9.3	7.8	4.3	5.6
EBITDA [+]	-18.9	-18.6	-13.1	-10.8	-10.3
EBITDA growth	2.0%	41.4%	21.7%	4.6%
EBITDA margin	-28.5%	-27.5%	-27.7%	-47.6%	-63.6%
Depreciation and amortization	1.9	1.5	1.2	0.8	0.6
EBIT [+]	-20.9	-20.0	-14.3	-11.6	-10.9
EBIT growth	4.3%	40.1%	23.1%	6.1%
EBIT margin	-31.4%	-29.7%	-30.1%	-51.2%	-67.4%
Non-recurring items [+]		11.2
In-process research & development		11.2
Interest income	0.7	1.9	0.8	0.3	0.3
Interest income	0.7	1.9	0.8	0.3	0.3
Other income (expense), net	-0.7	0.1	0.1	-0.1	0.0
Pre-tax income	-20.9	-29.2	-13.4	-11.4	-10.7
Income taxes	0.2	0.3	0.2	0.0	0.0
Net income	-21.1	-29.5	-13.6	-11.4	-10.7
Net margin	-31.7%	-43.8%	-28.6%	-50.3%	-65.8%

Basic EPS [+]	($0.46)	($0.94)	($3.54)	($3.96)	($4.73)
Growth	-51.7%	-73.3%	-10.8%	-16.3%
Diluted EPS [+]	($0.46)	($0.94)	($3.54)	($3.96)	($4.73)
Growth	-51.7%	-73.3%	-10.8%	-16.3%

Shares outstanding (basic) [+]	46.3	31.3	3.8	2.9	2.3
Growth	48.1%	714.7%	33.6%	27.5%
Shares outstanding (diluted) [+]	46.3	31.3	3.8	2.9	2.3
Growth	48.1%	714.7%	33.6%	27.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.